“…Patients' electronic health records were screened for (1) IV vancomycin receipt for ≥48 h prior to stool collection, (2) ≥1 dose of IV vancomycin administered <24 h prior to stool collection (exception for hemodialysis patients with documented serum level), and (3) no oral vancomycin administration prior to stool collection. Factors associated with increased risk of vancomycin bowel penetration were collected and included renal function/renal replacement therapy, active bowel pathology (irritable bowel syndrome (IBS), diverticulitis, Crohn's disease, history of bariatric surgery, GI surgery within the last month, GI bleed within the last month), and active inflammatory states (active bowel pathology, active infection, shock as evidenced by vasopressor support, and active malignancy) [15,17,23,24]. This study was approved by the Committee for the Protection of Research Subjects at the University of Houston (CPHS000128).…”